» Articles » PMID: 39227758

Causal Relationships Between Neuropsychiatric Disorders and Nonalcoholic Fatty Liver Disease: A Bidirectional Mendelian Randomization Study

Overview
Publisher Biomed Central
Specialty Gastroenterology
Date 2024 Sep 3
PMID 39227758
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Increasing evidences suggest that nonalcoholic fatty liver disease (NAFLD) is associated with neuropsychiatric disorders. Nevertheless, whether there were causal associations between them remained vague. A causal association between neuropsychiatric disorders and NAFLD was investigated in this study.

Methods: We assessed the published genome-wide association study summary statistics for NAFLD, seven mental disorder-related diseases and six central nervous system dysfunction-related diseases. The causal relationships were first assessed using two-sample and multivariable Mendelian randomization (MR). Then, sensitivity analyses were performed, followed by a reverse MR analysis to determine whether reverse causality is possible. Finally, we performed replication analyses and combined the findings from the above studies.

Results: Our meta-analysis results showed NAFLD significantly increased the risk of anxiety disorders (OR = 1.016, 95% CI = 1.010-1.021, P value < 0.0001). In addition, major depressive disorder was the potential risk factor for NAFLD (OR = 1.233, 95% CI = 1.063-1.430, P value = 0.006). Multivariable MR analysis showed that the causal effect of major depressive disorder on NAFLD remained significant after considering body mass index, but the association disappeared after adjusting for the effect of waist circumference. Furthermore, other neuropsychiatric disorders and NAFLD were not found to be causally related.

Conclusions: These results implied causal relationships of NAFLD with anxiety disorders and Major Depressive Disorder. This study highlighted the need to recognize and understand the connection between neuropsychiatric disorders and NAFLD to prevent the development of related diseases.

Citing Articles

The curvilinear relationship between Framingham Steatosis Index and depression: insights from a nationwide study.

Jiang C, Wang B, Wang N, Wang J, Qu Y, Zhao G Front Psychiatry. 2025; 15:1510327.

PMID: 39957754 PMC: 11825442. DOI: 10.3389/fpsyt.2024.1510327.

References
1.
Burgess S, Butterworth A, Thompson S . Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013; 37(7):658-65. PMC: 4377079. DOI: 10.1002/gepi.21758. View

2.
Gulec M, Ozkol H, Selvi Y, Tuluce Y, Aydin A, Besiroglu L . Oxidative stress in patients with primary insomnia. Prog Neuropsychopharmacol Biol Psychiatry. 2012; 37(2):247-51. DOI: 10.1016/j.pnpbp.2012.02.011. View

3.
Lane J, Jones S, Dashti H, Wood A, Aragam K, van Hees V . Biological and clinical insights from genetics of insomnia symptoms. Nat Genet. 2019; 51(3):387-393. PMC: 6415688. DOI: 10.1038/s41588-019-0361-7. View

4.
Galiano Rus S, Ortiz Garcia de la Foz V, Arias-Loste M, Iruzubieta P, Gomez-Revuelta M, Juncal-Ruiz M . Elevated risk of liver steatosis in first-episode psychosis patients: Results from a 3-year prospective study. Schizophr Res. 2022; 246:30-38. DOI: 10.1016/j.schres.2022.06.001. View

5.
Baranova A, Zhao Q, Cao H, Chandhoke V, Zhang F . Causal influences of neuropsychiatric disorders on Alzheimer's disease. Transl Psychiatry. 2024; 14(1):114. PMC: 10891165. DOI: 10.1038/s41398-024-02822-1. View